Christopher Stogard

A Phase 1, Dose-Escalation, Pharmacokinetic and Pharmacodynamic Study of BIIB021 Administered Orally in Patients with Advanced Solid Tumors

C. Takimoto, D. V. Von Hoff, U. Banerji, 2013, Clinical Cancer Research.

Three Weeks of a Four Week Course or Twice Weekly for Four Weeks of a Four Week Course to Patients with Advanced Solid Tumors

C. Takimoto, U. Banerji, M. Saif, 2013 .